We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXRX
12676
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$112K ﹤0.01%
105
+53
+102% +$69.4K
MNOV icon
12677
CALL
MediciNova
MNOV
$64.5M
$111K ﹤0.01%
26,100
+9,000
+53% +$38.8K
MYPS icon
12678
PLAYSTUDIOS Inc
MYPS
$63.1M
$111K ﹤0.01%
14,957
-54,013
-78% -$523K
ONDS icon
12679
Ondas Inc
ONDS
$5.27B
$111K ﹤0.01%
13,944
-4,043
-22% -$31.8K
CNSY
12680
Cerenome, Inc. Common Stock
CNSY
$25.3M
$111K ﹤0.01%
+116
New +$105K
SMSI icon
12681
CALL
Smith Micro Software
SMSI
$16M
$111K ﹤0.01%
530
-673
-56% -$144K
VIOT
12682
Viomi Technology
VIOT
$47.2M
$111K ﹤0.01%
+13,033
New +$106K
ARBG
12683
DELISTED
Aequi Acquisition Corp
ARBG
$111K ﹤0.01%
+11,391
New +$111K
BLCM
12684
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$111K ﹤0.01%
33,617
-20,430
-38% -$65.6K
CHCI icon
12685
Comstock Holding Companies
CHCI
$175M
$110K ﹤0.01%
+18,356
New +$104K
CHR icon
12686
Cheer Holding
CHR
$3.43M
$110K ﹤0.01%
29
+18
+164% +$94.4K
CRVO icon
12687
CervoMed
CRVO
$36.9M
$110K ﹤0.01%
+2,015
New +$111K
FSP
12688
Franklin Street Properties
FSP
$50.8M
$110K ﹤0.01%
20,811
-893
-4% -$4.79K
GNLN icon
12689
CALL
Greenlane Holdings
GNLN
$1.22M
0
MREO
12690
PUT
Mereo BioPharma
MREO
$50.9M
$110K ﹤0.01%
34,700
-29,100
-46% -$97.6K
PTPI
12691
DELISTED
Petros Pharmaceuticals
PTPI
$110K ﹤0.01%
140
-2
-1% -$1.6K
RGS icon
12692
CALL
Regis Corp
RGS
$69.3M
$110K ﹤0.01%
585
-590
-50% -$126K
TARA icon
12693
CALL
Protara Therapeutics
TARA
$235M
$110K ﹤0.01%
+11,300
New +$128K
COMS
12694
PUT
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$110K ﹤0.01%
476
+59
+14% +$13.7K
BTAQU
12695
DELISTED
Burgundy Technology Acquisition Corporation Unit
BTAQU
$110K ﹤0.01%
+10,717
New +$111K
ARAY icon
12696
CALL
Accuray
ARAY
$33.2M
$109K ﹤0.01%
24,100
+9,300
+63% +$43.5K
ATXS
12697
CALL
DELISTED
Astria Therapeutics
ATXS
$109K ﹤0.01%
8,617
+6,600
+327% +$85.7K
BMRA icon
12698
CALL
Biomerica
BMRA
$4.88M
$109K ﹤0.01%
3,388
-350
-9% -$11.9K
SMFG icon
12699
CALL
Sumitomo Mitsui Financial
SMFG
$167B
$109K ﹤0.01%
+15,800
New +$113K
WATT icon
12700
Energous
WATT
$85.6M
$109K ﹤0.01%
63
-121
-66% -$220K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.